Effect of Surgical Revascularization on Hemorrhagic Moyamoya Disease (ESRHMMD)
Moyamoya Disease
About this trial
This is an interventional treatment trial for Moyamoya Disease focused on measuring revascularization, hemorrhagic moyamoya disease
Eligibility Criteria
Inclusion Criteria:
- DSA/MRA shows stenosis or occlusion in the distal internal carotid artery or the proximal portion of anterior/middle cerebral artery
- Abnormal vascular network appeared in the brain
- Lesions showed bilateral changes
- Age≥18 years
- With the onset of cerebral hemorrhage
- No cerebral infarction or cerebral hemorrhage occurred within the last month
- At least one month after the acute phase of cerebral hemorrhage or related diseases was treated
Exclusion Criteria:
- Patients with moyamoya syndrome secondary to systemic diseases such as arteriosclerosis, sickle cell anemia, radiation therapy, etc..
- Patients with severe mental disorders such as psychosis, liver and kidney dysfunction, poor blood pressure or blood glucose control, severe depression and substance abuse, low IQ, and acute phase of severe stroke with definite limb dysfunction should also be excluded.
Sites / Locations
- The 307th Hospital of Military Chinese People's Liberation ArmyRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Experimental
Experimental
Conservative treatment
Indirect vascular reconstruction surgery
direct vascular reconstruction surgery
Conservative treatment. The conservative treatment of hemorrhagic moyamoya disease mainly includes the control of hypertension, the prevention and treatment of secondary epilepsy, the control of intracranial hypertension(including the application of mannitol and glycerol fructose, etc.), and the corresponding symptomatic and neurotrophic treatment. Non-specific treatment is mainly deal with intracranial hematoma, including intraventricular drainage, intracranial hematoma evacuation, and ventriculoperitoneal shunt.
Indirect vascular reconstruction surgery. In addition to the pharmacotherapy used in conservative treatment, encephalo-duro-arterio-synangiosis(EDAS) is performed. The surgery is performed according to the procedures described by Matsushima.
Direct vascular reconstruction surgery. In addition to the pharmacotherapy used in conservative treatment, the superficial temporal artery(STA) and middle cerebral artery(MCA) bypass surgery is performed. The operation is the modified EDAS which basically similar to EDAS, but the surgical incision is as low as possible. And if necessary, the STA may not be preserved. The bone flap should be large enough to select the right recipient blood vessel.